| Recent progress on the versatility of virus-like particles C Qian, X Liu, Q Xu, Z Wang, J Chen, T Li, Q Zheng, H Yu, Y Gu, S Li, ... Vaccines 8 (1), 139, 2020 | 161 | 2020 |
| Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer X Liu, J Deng, Y Yuan, W Chen, W Sun, Y Wang, H Huang, B Liang, ... Pharmacology & Therapeutics 239, 108296, 2022 | 71 | 2022 |
| Multi-material electrospinning: from methods to biomedical applications J Xing, M Zhang, X Liu, C Wang, N Xu, D Xing Materials Today Bio, 100710, 2023 | 60 | 2023 |
| Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics B Liang, Y Yuan, XJ Peng, XL Liu, XK Hu, DM Xing Frontiers in cellular and infection microbiology 12, 1042070, 2022 | 51 | 2022 |
| Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity Z Li, S Song, M He, D Wang, J Shi, X Liu, Y Li, X Chi, S Wei, Y Yang, ... Nature Communications 9 (1), 5360, 2018 | 44 | 2018 |
| Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles D Wang, X Liu, M Wei, C Qian, S Song, J Chen, Z Wang, Q Xu, Y Yang, ... Nature communications 11 (1), 2841, 2020 | 36 | 2020 |
| Crystal structures of two immune complexes identify determinants for viral infectivity and type-specific neutralization of human papillomavirus Z Li, D Wang, Y Gu, S Song, M He, J Shi, X Liu, S Wei, J Li, H Yu, Q Zheng, ... MBio 8 (5), 10.1128/mbio. 00787-17, 2017 | 26 | 2017 |
| A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16. V5 L Xia, Y Xian, D Wang, Y Chen, X Huang, X Bi, H Yu, Z Fu, X Liu, S Li, ... Scientific reports 6 (1), 19042, 2016 | 21 | 2016 |
| Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection X Liu, J Chen, Z Wang, D Wang, M He, C Qian, S Song, X Chi, Z Kong, ... Emerging Microbes & Infections 8 (1), 1721-1733, 2019 | 17 | 2019 |
| Viral neutralization by antibody-imposed physical disruption Q Zheng, J Jiang, M He, Z Zheng, H Yu, T Li, W Xue, Z Tang, D Ying, Z Li, ... Proceedings of the National Academy of Sciences 116 (52), 26933-26940, 2019 | 16 | 2019 |
| The role and transformative potential of IL-19 in atherosclerosis W Chen, J Xing, X Liu, S Wang, D Xing Cytokine & Growth Factor Reviews 62, 70-82, 2021 | 15 | 2021 |
| Advanced function, design and application of skin substitutes for skin regeneration M Zhang, J Xing, Y Zhong, T Zhang, X Liu, D Xing Materials Today Bio 24, 100918, 2024 | 14 | 2024 |
| A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA. 1 through a unique binding mode D Zhao, L Liu, X Liu, J Zhang, Y Yin, L Luan, D Jiang, X Yang, L Li, ... Journal of Nanobiotechnology 20 (1), 411, 2022 | 14 | 2022 |
| The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy X Liu, J Deng, R Zhang, J Xing, Y Wu, W Chen, B Liang, D Xing, J Xu, ... Frontiers in Immunology 14, 1335252, 2023 | 12 | 2023 |
| Trop2-targeted therapies in solid tumors: advances and future directions X Liu, L Ma, J Li, L Sun, Y Yang, T Liu, D Xing, S Yan, M Zhang Theranostics 14 (9), 3674, 2024 | 11 | 2024 |
| Targeting NAD+: is it a common strategy to delay heart aging? Y Yuan, B Liang, XL Liu, WJ Liu, BH Huang, SB Yang, YZ Gao, JS Meng, ... Cell death discovery 8 (1), 230, 2022 | 11 | 2022 |
| Targeting Trop2 in solid tumors: a look into structures and novel epitopes X Liu, J Li, J Deng, J Zhao, G Zhao, T Zhang, H Jiang, B Liang, D Xing, ... Frontiers in Immunology 14, 1332489, 2023 | 9 | 2023 |
| A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells X Liu, L Luan, X Liu, D Jiang, J Deng, J Xu, Y Yuan, J Xing, B Chen, ... Frontiers in Immunology 14, 1292839, 2023 | 9 | 2023 |
| Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of binding M He, X Chi, Z Zha, Y Li, J Chen, Y Huang, S Huang, M Yu, Z Wang, ... Journal of Virology 95 (7), 10.1128/jvi. 01587-20, 2021 | 8 | 2021 |
| Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli D Wang, F Fan, Z Li, X Liu, S Song, S Wei, M He, Y Lin, Z Li, M Wei, H Yu, ... Protein Expression and Purification 133, 110-120, 2017 | 8 | 2017 |
Qingbing ZhengXiamen University確認したメール アドレス: xmu.edu.cn